Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2016 (2016), Article ID 9802086, 11 pages
http://dx.doi.org/10.1155/2016/9802086
Research Article

Aromatase Expression in the Hippocampus of AD Patients and 5xFAD Mice

1Department of Cell Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
2Institute of Neuroanatomy, University Medical Center Hamburg Eppendorf, Martinistraße 52, 20246 Hamburg, Germany
3Institute of Neuropathology, University Medical Center Hamburg Eppendorf, Martinistraße 52, 20246 Hamburg, Germany

Received 9 December 2015; Revised 26 March 2016; Accepted 5 April 2016

Academic Editor: Ayanabha Chakraborti

Copyright © 2016 Janine Prange-Kiel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Azcoitia, J. G. Yague, and L. M. Garcia-Segura, “Estradiol synthesis within the human brain,” Neuroscience, vol. 191, pp. 139–147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. F. Roselli, “Brain aromatase: roles in reproduction and neuroprotection,” Journal of Steroid Biochemistry and Molecular Biology, vol. 106, no. 1–5, pp. 143–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Stoffel-Wagner, M. Watzka, J. Schramm, F. Bidlingmaier, and D. Klingmüller, “Expression of CYP19 (aromatase) mRNA in different areas of the human brain,” Journal of Steroid Biochemistry and Molecular Biology, vol. 70, no. 4–6, pp. 237–241, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. R. C. Melcangi, G. Panzica, and L. M. Garcia-Segura, “Neuroactive steroids: focus on human brain,” Neuroscience, vol. 191, pp. 1–5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. C. J. Saldanha, K. A. Duncan, and B. J. Walters, “Neuroprotective actions of brain aromatase,” Frontiers in Neuroendocrinology, vol. 30, no. 2, pp. 106–118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. W. G. Honer, “Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals,” Neurobiology of Aging, vol. 24, no. 8, pp. 1047–1062, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Knobloch and I. M. Mansuy, “Dendritic spine loss and synaptic alterations in Alzheimer's disease,” Molecular Neurobiology, vol. 37, no. 1, pp. 73–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. A. Mann, “Pyramidal nerve cell loss in Alzheimer's disease,” Neurodegeneration, vol. 5, no. 4, pp. 423–427, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. V. De-Paula, M. Radanovic, B. S. Diniz, and O. V. Forlenza, “Alzheimer’s disease,” in Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease, J. R. Harris, Ed., pp. 329–352, Springer, Rotterdam, Netherlands, 2012. View at Google Scholar
  10. C. Sturchler-Pierrat, D. Abramowski, M. Duke et al., “Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 24, pp. 13287–13292, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Sturchler-Pierrat and M. Staufenbiel, “Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model,” Annals of the New York Academy of Sciences, vol. 920, pp. 134–139, 2000. View at Google Scholar · View at Scopus
  12. X. Yue, M. Lu, T. Lancaster et al., “Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 52, pp. 19198–19203, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. C. McAllister, J. Long, A. Bowers et al., “Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates β-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment,” The Journal of Neuroscience, vol. 30, no. 21, pp. 7326–7334, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Li and M. Singh, “Sex differences in cognitive impairment and Alzheimer's disease,” Frontiers in Neuroendocrinology, vol. 35, no. 3, pp. 385–403, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. E. R. Simpson, “Aromatase: biologic relevance of tissue-specific expression,” Seminars in Reproductive Medicine, vol. 22, no. 1, pp. 11–23, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Honda, N. Harada, and Y. Takagi, “Novel exon 1 of the aromatase gene specific for aromatase transcripts in human brain,” Biochemical and Biophysical Research Communications, vol. 198, no. 3, pp. 1153–1160, 1994. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Sasano, K. Takahashi, F. Satoh, H. Nagura, and N. Harada, “Aromatase in the human central nervous system,” Clinical Endocrinology, vol. 48, no. 3, pp. 325–329, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. J. G. Yague, A. Muñoz, P. De Monasterio-Schrader, J. DeFelipe, L. M. Garcia-Segura, and I. Azcoitia, “Aromatase expression in the human temporal cortex,” Neuroscience, vol. 138, no. 2, pp. 389–401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Bobinski, M. J. de Leon, M. Tarnawski et al., “Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease,” Brain Research, vol. 805, no. 1-2, pp. 267–269, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Oakley, S. L. Cole, S. Logan et al., “Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation,” The Journal of Neuroscience, vol. 26, no. 40, pp. 10129–10140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Beyer, S. J. Green, P. J. Barker, N. S. Huskisson, and J. B. Hutchinson, “Aromatase-immunoreactivity is localised specifically in neurones in the developing mouse hypothalamus and cortex,” Brain Research, vol. 638, no. 1-2, pp. 203–210, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Prange-Kiel, H. Jarry, M. Schoen et al., “Gonadotropin-releasing hormone regulates spine density via its regulatory role in hippocampal estrogen synthesis,” The Journal of Cell Biology, vol. 180, no. 2, pp. 417–426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Prange-Kiel, U. Wehrenberg, H. Jarry, and G. M. Rune, “Para/autocrine regulation of estrogen receptors in hippocampal neurons,” Hippocampus, vol. 13, no. 2, pp. 226–234, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Cai, X. O. Shu, K. M. Egan et al., “Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women,” Pharmacogenetics and Genomics, vol. 18, no. 8, pp. 657–664, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. S. Mahendroo, C. R. Mendelson, and E. R. Simpson, “Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue,” The Journal of Biological Chemistry, vol. 268, no. 26, pp. 19463–19470, 1993. View at Google Scholar · View at Scopus
  26. M. Shozu, Y. Zhao, S. E. Bulun, and E. R. Simpson, “Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6,” Endocrinology, vol. 139, no. 4, pp. 1610–1617, 1998. View at Google Scholar · View at Scopus
  27. E. R. Simpson, M. S. Mahendroo, G. D. Means et al., “Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis,” Endocrine Reviews, vol. 15, no. 3, pp. 342–355, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. M. B. Yilmaz, A. Wolfe, Y.-H. Cheng, C. Glidewell-Kenney, J. L. Jameson, and S. E. Bulun, “Aromatase promoter I.f is regulated by estrogen receptor alpha (ESR1) in mouse hypothalamic neuronal cell lines,” Biology of Reproduction, vol. 81, no. 5, pp. 956–965, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. P. F. Durrenberger, S. Fernando, S. N. Kashefi et al., “Effects of antemortem and postmortem variables on human brain mRNA quality: a brainNet Europe study,” Journal of Neuropathology and Experimental Neurology, vol. 69, no. 1, pp. 70–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. Yague, I. Azcoitia, J. DeFelipe, L. M. Garcia-Segura, and A. Muñoz, “Aromatase expression in the normal and epileptic human hippocampus,” Brain Research, vol. 1315, pp. 41–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. T. A. Ishunina, D. van Beurden, G. van der Meulen et al., “Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease,” Neurobiology of Aging, vol. 26, no. 2, pp. 173–194, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Luchetti, K. Bossers, S. Van de Bilt et al., “Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease,” Neurobiology of Aging, vol. 32, no. 11, pp. 1964–1976, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Barron and C. J. Pike, “Sex hormones, aging, and Alzheimer's disease,” Frontiers in Bioscience, vol. 4, no. 3, pp. 976–997, 2012. View at Google Scholar · View at Scopus
  34. Y. D. Goodman, A. J. Bruce, B. Cheng, and M. P. Mattson, “Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons,” Journal of Neurochemistry, vol. 66, no. 5, pp. 1836–1844, 1996. View at Google Scholar · View at Scopus
  35. C. J. Pike, J. C. Carroll, E. R. Rosario, and A. M. Barron, “Protective actions of sex steroid hormones in Alzheimer's disease,” Frontiers in Neuroendocrinology, vol. 30, no. 2, pp. 239–258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Grimm, E. E. Biliouris, U. E. Lang, J. Götz, A. G. Mensah-Nyagan, and A. Eckert, “Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein,” Cellular and Molecular Life Sciences, vol. 73, no. 1, pp. 201–215, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Cui, Y. Wang, Q. Dong et al., “Morphine protects against intracellular amyloid toxicity by inducing estradiol release and upregulation of Hsp70,” The Journal of Neuroscience, vol. 31, no. 45, pp. 16227–16240, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. P. K.-Y. Chang, S. Boridy, R. A. McKinney, and D. Maysinger, “Letrozole potentiates mitochondrial and dendritic spine impairments induced by β amyloid,” Journal of Aging Research, vol. 2013, Article ID 538979, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Fester, L. Zhou, A. Bütow et al., “Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus,” Hippocampus, vol. 19, no. 8, pp. 692–705, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. L. M. Garcia-Segura, “Aromatase in the brain: not just for reproduction anymore,” Journal of Neuroendocrinology, vol. 20, no. 6, pp. 705–712, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. E. R. Rosario, L. Chang, E. H. Head, F. Z. Stanczyk, and C. J. Pike, “Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease,” Neurobiology of Aging, vol. 32, no. 4, pp. 604–613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Prange-Kiel, L. Fester, L. Zhou, H. Lauke, J. Carrétero, and G. M. Rune, “Inhibition of hippocampal estrogen synthesis causes region-specific downregulation of synaptic protein expression in hippocampal neurons,” Hippocampus, vol. 16, no. 5, pp. 464–471, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Harada, “Aberrant expression of aromatase in breast cancer tissues,” Journal of Steroid Biochemistry and Molecular Biology, vol. 61, no. 3–6, pp. 175–184, 1997. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Honma, K. Takubo, M. Sawabe et al., “Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years,” Breast Cancer Research, vol. 11, article R48, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Wang, R. Li, and Y. Hu, “The alternative noncoding exons 1 of aromatase (Cyp19) gene modulate gene expression in a posttranscriptional manner,” Endocrinology, vol. 150, no. 7, pp. 3301–3307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. G. E. Gillies and S. McArthur, “Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines,” Pharmacological Reviews, vol. 62, no. 2, pp. 155–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. B. B. Sherwin, “Estrogen and cognitive aging in women,” Trends in Pharmacological Sciences, vol. 23, no. 11, pp. 527–534, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Li, P. He, J. Cui, M. Staufenbiel, N. Harada, and Y. Shen, “Brain endogenous estrogen levels determine responses to estrogen replacement therapy via regulation of BACE1 and NEP in female Alzheimer's transgenic mice,” Molecular Neurobiology, vol. 47, no. 3, pp. 857–867, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. V. Hanoux, H. Bouraïma, H. Mittre, C. Féral, and A. Benhaïm, “Differential regulation of two 3′ end variants of P450 aromatase transcripts and of a new truncated aromatase protein in rabbit preovulatory granulosa cells,” Endocrinology, vol. 144, no. 11, pp. 4790–4798, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Levallet, B. Bilinska, H. Mittre, C. Genissel, J. Fresnel, and S. Carreau, “Expression and immunolocalization of functional cytochrome p450 aromatase in mature rat testicular cells,” Biology of Reproduction, vol. 58, no. 4, pp. 919–926, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Pezzi, M. L. Panno, R. Sirianni et al., “Effects of tri-iodothyronine on alternative splicing events in the coding region of cytochrome P450 aromatase in immature rat Sertoli cells,” Journal of Endocrinology, vol. 170, no. 2, pp. 381–393, 2001. View at Publisher · View at Google Scholar · View at Scopus